These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35997952)

  • 21. Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.
    Qiu Y; Chen BL; Feng R; Zhang SH; He Y; Zeng ZR; Ben-Horin S; Peyrin-Biroulet L; Mao R; Chen MH
    J Gastroenterol Hepatol; 2018 Mar; 33(3):664-670. PubMed ID: 28940780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
    Ranjan MK; Kante B; Vuyyuru SK; Kumar P; Mundhra SK; Golla R; Sharma R; Sahni P; Das P; Makharia G; Kedia S; Ahuja V
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1544-1553. PubMed ID: 35501287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.
    Savelkoul EHJ; Maas MHJ; Bourgonje AR; Crouwel F; Biemans VBC; den Broeder N; Russel MGVM; Römkens TEH; de Boer NK; Dijkstra G; Hoentjen F
    J Crohns Colitis; 2022 Sep; 16(9):1372-1379. PubMed ID: 35303065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ
    Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for surgery in stricturing small bowel Crohn's disease: A retrospective cohort study from the GETAID pédiatrique.
    Lacotte E; Boujonnier L; Martinez-Vinson C; Viala J; Ley D; Coopman S; Lerisson H; Dabadie A; Dumant-Forrest C; Pigneur B; Ruemmele F; Enaud R; Comte A; Rebeuh J; Bertrand V; Caron N; Breton A; Duclaux-Loras R; Vasies I; Dupont-Lucas C
    J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1261-1272. PubMed ID: 38651614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
    Peyrin-Biroulet L; Salleron J; Filippi J; Reenaers C; Antunes O; Filipe V; Louis E; Hébuterne X; Roblin X
    J Crohns Colitis; 2016 May; 10(5):516-24. PubMed ID: 26802084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.
    Lakatos PL; Czegledi Z; Szamosi T; Banai J; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp J; Lakatos L
    World J Gastroenterol; 2009 Jul; 15(28):3504-10. PubMed ID: 19630105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
    Atia O; Friss C; Ledderman N; Greenfeld S; Kariv R; Daher S; Yanai H; Loewenberg Weisband Y; Matz E; Dotan I; Turner D
    J Crohns Colitis; 2023 Nov; 17(10):1614-1623. PubMed ID: 37099729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adalimumab for maintenance of remission in Crohn's disease.
    Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Vasudevan A; Raghunath A; Anthony S; Scanlon C; Sparrow MP; Gibson PR; van Langenberg DR
    Dig Dis Sci; 2019 Jun; 64(6):1622-1631. PubMed ID: 30560332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
    Fan Y; Zhang L; Omidakhsh N; Bohn RL; Thompson JS; Brodovicz KG; Deepak P
    Inflamm Bowel Dis; 2023 Jun; 29(6):914-922. PubMed ID: 35880838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease.
    Ranjan MK; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Golla R; Sharma R; Sahni P; Das P; Makharia G; Kedia S; Ahuja V
    Int J Colorectal Dis; 2022 Aug; 37(8):1817-1826. PubMed ID: 35835862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
    Mesonero F; Castro-Poceiro J; Benítez JM; Camps B; Iborra M; López-García A; Torres P; Esteve M; Tosca J; Bertoletti F; Almela P; Calvet X; Vera I; Bujanda L; Gomollón F; Rodríguez C; Antolín B; Busquets D; Hernández A; Rivero M; Monfort I Miquel D; Castaño-García A; Gisbert JP; Domènech E; López-Sanromán A;
    Aliment Pharmacol Ther; 2021 May; 53(9):1021-1029. PubMed ID: 33715177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.